Shi X - Search Results

1

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.

Sun X, Wang X, Zhou J, Xu Y, Zhang H, Xu M, Shen J, Shi X, Song W, Li J. Sun X, et al. Among authors: shi x. Medicine (Baltimore). 2023 May 26;102(21):e33858. doi: 10.1097/MD.0000000000033858. Medicine (Baltimore). 2023. PMID: 37233406 Free PMC article.

2

An advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report.

Yang R, Wang D, Li X, Mao K, Wang J, Li P, Shi X, Zhang S, Wang Y. Yang R, et al. Among authors: shi x. Ann Transl Med. 2022 Mar;10(6):381. doi: 10.21037/atm-22-403. Ann Transl Med. 2022. PMID: 35433927 Free PMC article.

3

Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non‑small cell lung cancer.

Hu J, Shang Y, Shi X, Zhang S, Shi J, Yao M, Wang A, Shou T, Shi W, Wang K, Liu A, Pan X, Wang Y. Hu J, et al. Among authors: shi x, shi j, shi w. Oncol Rep. 2020 Jun;43(6):2053-2061. doi: 10.3892/or.2020.7559. Epub 2020 Mar 23. Oncol Rep. 2020. PMID: 32236597

4

A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.

Zhang Y, Shi X, Zhang J, Chen X, Zhang P, Liu A, Zhu T. Zhang Y, et al. Among authors: shi x. Sci Rep. 2021 Jan 11;11(1):387. doi: 10.1038/s41598-020-79694-0. Sci Rep. 2021. PMID: 33432021 Free PMC article.

5

Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates.

Yang Q, Shen R, Xu H, Shi X, Xu L, Zhang L, Fan X, Jin X. Yang Q, et al. Among authors: shi x. Ann Transl Med. 2021 Mar;9(6):465. doi: 10.21037/atm-21-289. Ann Transl Med. 2021. PMID: 33850862 Free PMC article.

6

Antitumor activity of everolimus in recurrent metastatic endometrial cancer with PTEN deletion: a case report.

Zhang X, Shi J, Li J, Shi X, Liu X, Zhang Y, Cui Y. Zhang X, et al. Among authors: shi x, shi j. Gland Surg. 2021 Aug;10(8):2585-2590. doi: 10.21037/gs-21-422. Gland Surg. 2021. PMID: 34527569 Free PMC article.

7

Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report.

Fang G, Liu W, Shang Y, Huo R, Shi X, Wang Y, Li J. Fang G, et al. Among authors: shi x. Ann Transl Med. 2022 Jan;10(2):115. doi: 10.21037/atm-21-6991. Ann Transl Med. 2022. PMID: 35282065 Free PMC article.

8

Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.

Jiang G, Zhang W, Wang T, Ding S, Shi X, Zhang S, Shi W, Liu A, Zheng S. Jiang G, et al. Among authors: shi x, shi w. Jpn J Clin Oncol. 2020 Sep 28;50(10):1117-1125. doi: 10.1093/jjco/hyaa088. Jpn J Clin Oncol. 2020. PMID: 32533190

9

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.

Shang Y, Li X, Liu W, Shi X, Yuan S, Huo R, Fang G, Han X, Zhang J, Wang K, Dou Z, Zhang Y, Zang A, Zhang L. Shang Y, et al. Among authors: shi x. Sci Rep. 2020 Nov 20;10(1):20243. doi: 10.1038/s41598-020-76791-y. Sci Rep. 2020. PMID: 33219256 Free PMC article.

10

Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.

Zhang N, Shi J, Shi X, Chen W, Liu J. Zhang N, et al. Among authors: shi x, shi j. Onco Targets Ther. 2020 Dec 14;13:12797-12809. doi: 10.2147/OTT.S275688. eCollection 2020. Onco Targets Ther. 2020. PMID: 33363385 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,147 results

Search Page

Filters